Pitressin toxicity in diabetes insipidus, and the therapeutic superiority of the nasal route for replacement therapy; report of a case.
D001127:Arginine Vasopressin; D003919:Diabetes Insipidus / Q000628:therapy*; D020790:Diabetes Insipidus, Neurogenic; D006801:Humans; D014667:Vasopressins / Q000008:administration & dosage*
D014667:Vasopressins; D001127:Arginine Vasopressin
DIABETES INSIPIDUS/therapy; VASOPRESSIN/administration